AI Summary
This article discusses the optimization of 2-aminopyrimidine-based macrocycles to develop potent inhibitors of EPHA2/GAK kinases. The research focuses on improving the efficacy of these inhibitors for potential therapeutic applications. The findings highlight the importance of structure-activity relationship studies in drug development.